Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-11
2007-09-11
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S254090, C514S330000, C514S407000, C514S438000, C514S442000, C514S474000
Reexamination Certificate
active
10651934
ABSTRACT:
The invention is directed to methods of bone healing by administering a p38 MAP kinase inhibitor. The invention is directed to methods of treating bone fractures, bone diseases, bone grafting, especially enhancing bone healing following facial reconstruction, maxillary reconstruction, mandibular reconstruction or tooth extraction, enhancing long bone extension, enhancing prosthetic ingrowth, and increasing bone synostosis by administering a p38 MAP kinase inhibitor.
REFERENCES:
patent: 4107288 (1978-08-01), Oppenheim et al.
patent: 4619652 (1986-10-01), Eckenhoff et al.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 6410540 (2002-06-01), Goehring et al.
patent: 2356263 (2000-07-01), None
patent: WO96/21452 (1996-07-01), None
patent: WO96/21654 (1996-07-01), None
patent: WO96/40143 (1996-12-01), None
patent: WO97/25046 (1997-07-01), None
patent: WO97/35856 (1997-10-01), None
patent: WO98/25619 (1998-06-01), None
patent: WO98/56377 (1998-12-01), None
patent: WO98/57966 (1998-12-01), None
patent: WO99/32110 (1999-07-01), None
patent: WO99/32121 (1999-07-01), None
patent: WO99/32463 (1999-07-01), None
patent: WO99/57101 (1999-11-01), None
patent: WO99/61440 (1999-12-01), None
patent: WO99/64400 (1999-12-01), None
patent: WO 00/10563 (2000-03-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/17204 (2000-03-01), None
patent: WO 00/19824 (2000-04-01), None
patent: WO 00/26209 (2000-05-01), None
patent: WO 00/41698 (2000-07-01), None
patent: WO 00/64422 (2000-11-01), None
patent: WO 00/71535 (2000-11-01), None
patent: WO 01/05749 (2001-01-01), None
patent: WO 01/10865 (2001-02-01), None
patent: WO 01/38324 (2001-05-01), None
patent: WO 01/64679 (2001-09-01), None
patent: WO 01/66539 (2001-09-01), None
patent: WO 01/66540 (2001-09-01), None
patent: WO 02/07772 (2002-01-01), None
De Laszlo et al. “Pyrroles and Other Heterocycles as Inhibitors of P38 Kinase”, Bioorganic & Medicinal Chemistry Letters vol. 8, pp. 2689-2694 (1998).
Tuli et al., “p38 MAP Kinase Regulation of AP-2 Binding in TGF-beta 1-Stimulated Chrondrogenesis of Human Trabecular Bone-Derived Cells”, Annals of New Yorks Academy of Science, vol. 961, pp. 172-177 (2002).
International Search Report for PCT/US03/26839, mailed on Aug. 16, 2004, 4 pages.
Adams et al., Bioorg. Med. Chem. Lett., 8:3111-3116 (1998).
Adler, Bone Diseases, p. 114(Springer-Verlag, Germany 2000).
Bell et al., J. Physiol., 100:299-317 (1941).
Bonnarens and Einhorn, J. Orthop. Res., 2:97-101 (1984).
Collis et al., Bioorg. Med. Chem. Lett., 11:693-696 (2001).
De Laszlo et al., Bioorg. Med. Chem. Lett., 8:2698 (1998).
Engesaeter et al., Acta Orthop. Scand., 49:512-518 (1978).
Fijen et al., Clin. Exp. Immunol., 124:16-20 (2001).
Gallagher et al., Bioorg. Med. Chem., 5:49-64 (1997).
Jiang et al., J. Biol. Chem., 271:17920-17926 (1996).
Kimble et al., Endocrinol., 136:3054-3061 (1995).
Kumar et al., Biochem. Biophys. Res. Comm., 235:533-538 (1997).
Lee et al., Bone, 30(1):71-77 (2002).
Li et al., Biochem. Biophys. Res. Comm., 228:334-340 (1996).
Li et al., Endocrinology, 143:3105-3113 (2002).
Matsumoto et al., FEBS Lett., 486:23-28 (2000).
Matsumoto et al., J. Biol. Chem., 275:31155-31161 (2000).
McLay et al., Bioorg. Med. Chem., 9:537-554 (2001).
Poste, Meth. Cell Biol. 14:33-71 (1976).
Report of a World Health Oraganization Study Group, World Health Organization Technical Series 843, “Assessment of a Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis” (1994).
Revesz et al., Bioorg. Med. Chem. Lett., 10:1261-1264 (2000).
Simon et al., J. Bone Miner. Res., 17:963-976 (2002).
Stein et al., J. Biol. Chem. 272:19509-19517 (1997).
Wadsworth et al., J. Pharmacol. Expt. Therapeut., 291:680-687 (1999).
Wang et al., J. Biol. Chem., 272:23668-23674 (1997).
Wang et al., J. Biol. Chem., 273:2161-2168 (1998).
Liu David Y.
O'Connor Patrick
Protter Andrew A.
Henley III Raymond J.
Morrison & Foerster / LLP
Scios Inc.
LandOfFree
Methods of promoting osteogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of promoting osteogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of promoting osteogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3742179